Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders

Compounds of formula (I): or pharmaceutically acceptable salts thereof, are opioid receptor modulators, e.g. mu-opioid receptor antagonists, neutral antagonists or inverse agonists, and are useful for the treatment of metabolic disorders including obesity.

Saved in:
Bibliographic Details
Main Authors FRY PETER TIMOTHY, DUPREE TOM BANKSIA, STEWART ALAN JOHN, BRADLEY STUART EDWARD, SAMBROOK-SMITH COLIN PETER, PROCTER MARTIN JAMES, SMYTH DONALD, HANRAHAN PATRICK ERIC, BLOXHAM JASON, SCHOFIELD KAREN LESLEY, KRULLE THOMAS MARTIN
Format Patent
LanguageEnglish
Published 02.10.2012
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:Compounds of formula (I): or pharmaceutically acceptable salts thereof, are opioid receptor modulators, e.g. mu-opioid receptor antagonists, neutral antagonists or inverse agonists, and are useful for the treatment of metabolic disorders including obesity.
Bibliography:Application Number: US20080601100